Sharon Smith

A new analysis found that patients diagnosed with a second primary melanoma were more likely to have a nevus phenotype and a higher risk score than those who only had a primary melanoma. Medscape Medical News source https://www.medscape.com/viewarticle/984768?src=rss

More comprehensive testing is needed to monitor risks of emerging diseases, according to researchers. Medscape Medical News source https://www.medscape.com/viewarticle/984763?src=rss

Variety dubbed Ozempic “the worst kept secret in Hollywood — especially given that its most enthusiastic users are not pre-diabetic and do not require the drug.” WebMD Health News source https://www.medscape.com/viewarticle/984758?src=rss

The FDA approval of teplizumab for the delay of type 1 diabetes highlights the need to cost-effectively identify those at risk who could potentially receive it. Medscape Medical News source https://www.medscape.com/viewarticle/984748?src=rss

AstraZeneca will acquire biotechnology company Neogene Therapeutics for up to $320 million, the London-listed drugmaker said on Tuesday, seeking to build its pipeline of cell-based cancer treatments. Reuters Health Information source https://www.medscape.com/viewarticle/984703?src=rss

Fluid biomarkers can identify certain tauopathies, neurodegenerative diseases that involve aggregated tau proteins, with an accuracy of more than 80%, new research suggests. Medscape Medical News source https://www.medscape.com/viewarticle/984720?src=rss

Despite the similarities Andrew Thomas noted and a colleague verified with anti-plagiarism software, the paper was not retracted, but was flagged with an expression of concern so readers can "draw their own conclusions." Retraction Watch source https://www.medscape.com/viewarticle/984719?src=rss